Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease.

Nuvoli, Barbara; Germoni, Sabrina; Morosetti, Carlotta; Santoro, Raffaela; Cortese, Giancarlo; Masi, Serena; Cordone, Iole; Galati, Rossella

Nuvoli, Barbara; Germoni, Sabrina; Morosetti, Carlotta; Santoro, Raffaela; Cortese, Giancarlo; Masi, Serena; Cordone, Iole; Galati, Rossella.

Afiliação

Nuvoli B; Molecular Medicine Area, Regina Elena National Cancer Institute, 00144, Rome, Italy.
Germoni S; S.A.F.U. Department, Regina Elena National Cancer Institute, Rome, Italy.
Morosetti C; Molecular Medicine Area, Regina Elena National Cancer Institute, 00144, Rome, Italy.
Santoro R; Molecular Medicine Area, Regina Elena National Cancer Institute, 00144, Rome, Italy.
Cortese G; S.A.F.U. Department, Regina Elena National Cancer Institute, Rome, Italy.
Masi S; Clinical Pathology, Regina Elena National Cancer Institute, Rome, Italy.
Cordone I; Clinical Pathology, Regina Elena National Cancer Institute, Rome, Italy.
Galati R; Molecular Medicine Area, Regina Elena National Cancer Institute, 00144, Rome, Italy. galati@ifo.it.

Mol Cancer ; 21(1): 214, 2022 Dec 09.

Article em En | MEDLINE | ID: mdl-36482446

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google